The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|8|1500-1512

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.8, 2012-06, pp. : 1500-1512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development

By  

Current Medicinal Chemistry, Vol. 21, Iss. 31, 2014-10 ,pp. : 3551-3575

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 2, 2004-06 ,pp. : 147-154

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Neuroimaging in Analgesic Drug Development

By Lawrence Jane   Mackey Sean C.  

Drugs in R&D, Vol. 9, Iss. 5, 2008-01 ,pp. : 323-334

Adis International

Access to resources Recommend Favorite

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1580-1592

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate and Schizophrenia

By  

Current Neuropharmacology, Vol. 1, Iss. 4, 2003-12 ,pp. : 351-370

Bentham Science Publishers

Access to resources Recommend Favorite